In this issue:
Feature: insulins and malignancy risk
Liraglutide versus exenatide in type 2 diabetes
Renal and retinal effects of enalapril and losartan
EAT: anti-inflammatories and bodyweight
Bodyweight in Pacific Islands families
Nephropathy progression in NZ: ethnic differences
NZ community-wide diabetes prevention intervention
Please login below to download this issue (PDF)